logo

Omeros Corp. (OMER)



Trade OMER now with
  Date
  Headline
11/8/2022 8:41:52 AM Omeros Gets Decision From FDA On Formal Dispute Resolution Request For Narsoplimab
10/3/2022 7:27:56 AM Omeros Announces Royalty Monetization Transaction With DRI Healthcare Trust
9/15/2022 12:01:18 PM Omeros Stock Slips 27%
9/15/2022 9:14:40 AM Omeros Announces Narsoplimab Treatment Results In Critically Ill COVID-19 Patients In I-SPY COVID Trial
8/17/2022 8:44:40 AM Omeros Gets Interim Response From FDA On Formal Dispute Resolution Request For Narsoplimab
7/29/2022 8:48:23 AM Omeros:FDA Grants Orphan Drug Designation To MASP-3 Inhibitor OMS906 For Paroxysmal Nocturnal Hemoglobinuria Treatment
12/23/2021 9:13:32 AM Omeros Completes Sale Of OMIDRIA Franchise To Rayner Surgical
12/2/2021 7:35:56 AM Omeros To Sell OMIDRIA Franchise To Rayner Surgical In Transaction Valued In Excess Of $1 Bln
11/5/2021 8:48:23 AM Omeros : Long-term Data Supportive Of Key Role For Lectin Pathway Inhibition In Future Management Of Patients With IgAN
10/18/2021 6:34:39 AM Omeros Receives CRL From FDA For BLA For Narsoplimab In The Treatment Of HSCT-TMA